Schedule 13D ownership disclosure
KARYOPHARM THERAPEUTICS INC
Security class unavailable · CUSIP: 48576U106
Event date: 2016-12-01
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,241,123
- Percent of class
- 5.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-17-008638
- Form type
- SC 13D
- Filer
- DELPHI VENTURES VIII LP
- CIK
- CIK 1436285
- Filed
- Feb 14, 2017
- Reporting period
- Dec 01, 2016
- Description
- Schedule 13D beneficial ownership